|
1
|
Menon G, Alkabban FM and Ferguson T:
Breast cancer. StatPearls. StatPearls Publishing; Treasure Island,
FL: 2025
|
|
2
|
Giaquinto AN, Sung H, Newman LA, Freedman
RA, Smith RA, Star J, Jemal A and Siegel RL: Breast cancer
statistics 2024. CA Cancer J Clin. 74:477–495. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ibragimova MK, Tsyganov MM, Kravtsova EA,
Tsydenova IA and Litviakov NV: Organ-specificity of breast cancer
metastasis. Int J Mol Sci. 24:156252023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Worden AN, Pittard EG, Stern M, Uline MJ
and Potts JD: The role of the CXCL12/CXCR4 signaling pathway in
regulating cellular migration. Microsc Microanal. 31:ozaf0112025.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Booth A, Magnuson A, Fouts J and Foster M:
Adipose tissue, obesity and adipokines: Role in cancer promotion.
Horm Mol Biol Clin Investig. 21:57–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li J and Jiang Z: Chinese society of
clinical oncology breast cancer (CSCO BC) guidelines in 2024:
International contributions from China. Cancer Biol Med.
21:838–843. 2024.PubMed/NCBI
|
|
8
|
Teichgraeber DC, Guirguis MS and Whitman
GJ: Breast cancer staging: Updates in the AJCC cancer staging
manual, 8th edition, and current challenges for radiologists, from
the AJR special series on cancer staging. AJR Am J Roentgenol.
217:278–290. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Elston CW and Ellis IO: Pathological
prognostic factors in breast cancer. I. The value of histological
grade in breast cancer: Experience from a large study with
long-term follow-up. Histopathology. 19:403–410. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Q, Huang R, Jin X, Bai X, Tang W, Wang
L, Karako K and Zhu W: Advances in research on receptor
heterogeneity in breast cancer liver metastasis. Biosci Trends.
19:165–172. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Almahfouz Nasser S, Sharma A, Saraf A,
Parulekar A, Haria P and Sethi A: Towards improving breast cancer
detection through multi-modal image generation. Ultrasonics.
153:1076552025. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Etan T, Amir E, Tibau A, Yerushalmi R,
Moore A, Shepshelovich D and Goldvaser H: National comprehensive
cancer network recommendations for drugs without US food and drug
administration approval in metastatic breast cancer: A
cross-sectional study. Cancer Treat Rev. 91:1021132020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Im SA, Gennari A, Park YH, Kim JH, Jiang
ZF, Gupta S, Fadjari TH, Tamura K, Mastura MY, Abesamis-Tiambeng
MLT, et al: Pan-Asian adapted ESMO clinical practice guidelines for
the diagnosis, staging and treatment of patients with metastatic
breast cancer. ESMO Open. 8:1015412023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leong SP, Pissas A, Scarato M, Gallon F,
Pissas MH, Amore M, Wu M, Faries MB and Lund AW: The lymphatic
system and sentinel lymph nodes: Conduit for cancer metastasis.
Clin Exp Metastasis. 39:139–157. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Loi S, Michiels S, Adams S, Loibl S,
Budczies J, Denkert C and Salgado R: The journey of
tumor-infiltrating lymphocytes as a biomarker in breast cancer:
Clinical utility in an era of checkpoint inhibition. Ann Oncol.
32:1236–1244. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bai X, Wu L, Dai J, Wang K, Shi H, Lu Z,
Ji G, Yu J and Xu Q: Rim enhancement and peripancreatic fat
stranding in preoperative MDCT as predictors for occult metastasis
in PDAC patients. Acad Radiol. 30:2954–2961. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Safi SA, Haeberle L, Rehders A, Fung S,
Vaghiri S, Roderburg C, Luedde T, Ziayee F, Esposito I, Fluegen G
and Knoefel WT: Neoadjuvant treatment lowers the risk of
mesopancreatic fat infiltration and local recurrence in patients
with pancreatic cancer. Cancers (Basel). 14:682021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu Q, Zhu Y, Hepler C, Zhang Q, Park J,
Gliniak C, Henry GH, Crewe C, Bu D, Zhang Z, et al: Adipocyte
mesenchymal transition contributes to mammary tumor progression.
Cell Rep. 40:1113622022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maguire OA, Ackerman SE, Szwed SK, Maganti
AV, Marchildon F, Huang X, Kramer DJ, Rosas-Villegas A, Gelfer RG,
Turner LE, et al: Creatine-mediated crosstalk between adipocytes
and cancer cells regulates obesity-driven breast cancer. Cell
Metab. 33:499–512.e6. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kothari C, Diorio C and Durocher F: The
importance of breast adipose tissue in breast cancer. Int J Mol
Sci. 21:57602020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song Y, Na H, Lee SE, Kim YM, Moon J, Nam
TW, Ji Y, Jin Y, Park JH, Cho SC, et al: Dysfunctional adipocytes
promote tumor progression through YAP/TAZ-dependent
cancer-associated adipocyte transformation. Nat Commun.
15:40522024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Q, Li B, Li Z, Li J and Sun S and Sun
S: Cancer-associated adipocytes: Key players in breast cancer
progression. J Hematol Oncol. 12:952019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Y, Ma X, Li Y, Jin L and Zhou X: The
evolving tumor-associated adipose tissue microenvironment in breast
cancer: From cancer initiation to metastatic outgrowth. Clin Transl
Oncol. 27:2778–2788. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dong Z, He L, Wu J, Xie C, Geng S, Wu J,
Zhong C and Li X: Bisphenol A-induced cancer-associated adipocytes
promotes breast carcinogenesis via CXCL12/AKT signaling. Mol Cell
Endocrinol. 599:1124732025. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Olszańska J, Pietraszek-Gremplewicz K,
Domagalski M and Nowak D: Mutual impact of adipocytes and
colorectal cancer cells growing in co-culture conditions. Cell
Commun Signal. 21:1302023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo B, Wang K, Wu J, Yu H, Geng C, Jin Y
and Song Y: Runx1 activates the transformation of adipocytes into
cancer-associated adipocytes by downregulating Plin1. Exp Cell Res.
448:1145732025. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guaita-Esteruelas S, Guma J, Masana L and
Borràs J: The peritumoural adipose tissue microenvironment and
cancer. The roles of fatty acid binding protein 4 and fatty acid
binding protein 5. Mol Cell Endocrinol. 462:107–118. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gradishar WJ, Moran MS, Abraham J,
Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Bailey J,
Burstein HJ, et al: Breast cancer, version 3.2024, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
22:331–357. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park M, Kim D, Ko S, Kim A, Mo K and Yoon
H: Breast cancer metastasis: Mechanisms and therapeutic
implications. Int J Mol Sci. 23:68062022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nieman KM, Romero IL, Van Houten B and
Lengyel E: Adipose tissue and adipocytes support tumorigenesis and
metastasis. Biochim Biophys Acta. 1831:1533–1541. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wakita T, Yamanaka K, Yoshimura A, Fukae
S, Yoshida T and Kishikawa H: Perirenal fat metastasis of prostate
cancer. Urol Case Rep. 39:1017782021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Anderson BO, Braun S, Carlson RW, Gralow
JR, Lagios MD, Lehman C, Schwartsmann G and Vargas HI: Overview of
breast health care guidelines for countries with limited resources.
Breast J. 9 (Suppl 2):S42–S50. 2003. View Article : Google Scholar : PubMed/NCBI
|
